Abstract
[Purpose] To examine whether functional independence measure scores and effectiveness at discharge can be predicted using N-terminal pro-B-type natriuretic peptide concentrations at admission in postoperative patients aged ≥75 years with proximal femur fractures. [Participants and Methods] This study included 35 patients who were admitted for rehabilitation after proximal femur fracture surgery between April 1, 2020 and September 20, 2023 and were discharged by November 30, 2023. The primary outcomes were the functional independence measure scores and effectiveness at discharge. The explanatory variables analyzed using multiple regression included demographic data; N-terminal pro-B-type natriuretic peptide concentration, estimated glomerular filtration rate, and geriatric nutritional risk index at admission; functional ambulation categories before injury; and motor, cognitive, and total functional independence measure scores at admission. [Results] The motor functional independence measure score at admission and N-terminal pro-B-type natriuretic peptide concentration were significant explanatory variables for the motor functional independence measure score at discharge. The N-terminal pro-B-type natriuretic peptide concentration was a significant explanatory variable in total and motor functional independence effectiveness. [Conclusion] This study, which excluded cognitively impaired patients and focused on individuals aged ≥75 years, suggests that N-terminal pro-B-type natriuretic peptide concentration at admission affects the functional independence measure scores and effectiveness at discharge.
Keywords: Proximal femur fracture, Heart failure, N-terminal pro-B-type natriuretic peptide
INTRODUCTION
The global population is aging at an unprecedented rate, with the proportion of older adults expected to rise from 9.4% in 2020 to 18.7% by 20421). This trend is particularly pronounced in Japan, where the aging population has remarkably increased. As of 2022, 29.0% of the Japanese population was aged 65 or older, and 15.5% was aged 75 or older, marking the highest aging rate in the world1). Bone mass peaks in one’s 20s, after which a balance between bone resorption and formation is maintained for a period. However, from around the age of 402), bone mass begins to decline, increasing the risk of fractures3). In Japan, the number of proximal femur fractures is projected to reach approximately 300,000 annually by 2030 and 320,000 by 2042, largely due to the aging population4).
Aging is also associated with an increased incidence of heart failure. A U.S. study reported that the incidence of new heart failure cases rises with age, affecting 1.3% of men and 0.7% of women in their 60s, and 8.3% of men and 7.8% of women in their 80s5). The global aging population has contributed to what is now termed a “heart failure pandemic”, with 26 million people worldwide affected6). In Japan, the number of patients with chronic heart failure is estimated to rise significantly due to the aging population and the increasing prevalence of ischemic heart disease. This number is expected to increase from approximately 1.1 million in 2015 to 1.3 million by 2030, continuing to increase until 20357).
Given the increasing aging population in Japan, the number of patients with heart failure undergoing proximal femur fracture surgery will rise. Consequently, establishing evidence-based practices is necessary for managing these complicated cases in the future.
There is some literature describing patients with complicated heart failure after proximal femur fracture surgery. Itagaki et al.8) reported that functional independence measure (FIMTM) effectiveness was lower in those with a history of heart failure compared with those without such a diagnosis. Tamamura et al.9) found that FIMTM gain and motor FIMTM effectiveness were lower in patients over 65 years of age with elevated B-type natriuretic peptide (BNP) levels. In addition, they reported that this trend was particularly pronounced in patients with BNP concentrations of 100 pg/mL or higher10). However, these reports did not exclude patients with cognitive impairments, leaving open the possibility that cognitive decline may influence ADL recovery. Additionally, these studies either lacked age criteria or included a wide age range (65 years and older). Given the correlation between age and the severity of heart failure, distinguishing between ADL capacity decline due to aging and that due to heart failure is difficult.
Therefore, this study aimed to investigate whether FIMTM scores and FIMTM effectiveness at discharge could be predicted using N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations at admission. The goal was to obtain basic data for predicting ADL recovery in elderly postoperative patients, aged 75 years or older, with proximal femur fractures and no cognitive impairment undergoing rehabilitation.
PARTICIPANTS AND METHODS
This study is a retrospective cohort study that examined predictors of FIMTM at discharge and FIMTM effectiveness using multiple regression analysis.
The target sample size was estimated in advance using G*Power 3.1.9.7 (Heinrich Heine University, Düsseldorf, Germany) (Effect size f2=0.5, α=0.05, Power=0.8, Number of predictors=8). Consequently, 39 participants were targeted for inclusion in the study. This study included patients who were admitted to Hikarigaoka Hospital for rehabilitation between April 1, 2020 and September 20, 2023 and were discharged by November 30 of the same year. The participants were patients aged 75 years or older with a first-time postoperative proximal femur fracture. Their plasma NT-proBNP concentrations were measured upon admission due to suspected heart failure. Out of 98 patients initially considered, 35 were ultimately included in the study. Patients were excluded if they had passed away in the hospital (n=1), were transferred to another hospital (n=4), had missing data (n=11), or scored 20 or lower (n=47) on the revised Hasegawa’s dementia scale (HDS-R)11).
The final sample consisted of 29 women and 6 men, with a mean age of 87.3 ± 6.4 years. Among these patients, 18 had a femoral neck fracture, and 17 had a trochanteric fracture. Regarding surgical intervention, 19 patients underwent osteosynthesis, while 16 underwent arthroplasty. This retrospective study evaluated and measured results within the context of routine medical care. All study participants provided informed consent, and the study design was approved by the appropriate Ethical Review Committee of Hikarigaoka Hospital (Acceptance No. 14) and the Kinjo University Ethical Review Committee (Notification No. 2024-05).
Referring to previous studies8, 12, 13) on the effect of proximal femur fracture surgery on ADL, we obtained basic information from medical records, including patient age, sex, disease name, length of hospitalization, and the interval between injury onset and hospital admission. Additionally, we gathered information on pre-injury functional ambulation categories (FAC), NT-proBNP concentrations, estimated glomerular filtration rate, cognitive function, and the geriatric nutritional risk index (GNRI).
The ability to perform ADL was assessed using FIMTM, which was then used to calculate FIMTM effectiveness. Total FIMTM effectiveness was calculated as total FIMTM gain / (126 points −total FIMTM at admission), motor FIMTM effectiveness as motor FIMTM gain / (91 points −exercise FIMTM at admission), and cognitive FIMTM effectiveness as cognitive FIMTM gain / (35 points −cognitive FIMTM at admission). The denominator represents the potential for improvement, while the numerator indicates the actual improvement, with effectiveness values ranging from 0 to 114). FIMTM measurements were conducted by the assigned physical or occupational therapist.
Cognitive function was assessed using the HDS-R11), with a score of 21 or higher considered normal and a score of 20 or lower indicating suspected dementia. In this study, a score of 20 or lower was considered as cognitive decline.
FAC was developed by Holden et al.15) as a method to assess walking ability across six levels. This classification does not consider the use of walking aids, such as braces and canes. Pre-fracture gait ability has been reported to affect FIMTM effectiveness in patients recovering from hip fractures8). In this study, the FAC score before injury was obtained from medical records.
NT-proBNP is a circulating hormone biosynthesized and secreted by cardiac myocytes. It plays a role in diuresis, natriuresis, relaxation of vascular smooth muscle, and inhibition of aldosterone secretion16). It is secreted by the myocardium in response to increased cardiac preload and myocardial stretching17). NT-proBNP concentration increases in proportion to the severity of both left and right heart failure18). According to the “Guidelines for the Diagnosis of Acute and Chronic Heart Failure”19), the measurement of NT-proBNP and BNP levels is strongly recommended (class I) for diagnosing, determining the severity, and prognostic evaluation of heart failure. Additionally, it is considered class IIa for guiding treatment decisions and screening for heart failure.
The GNRI is a tool used to assess the nutritional status of elderly individuals. It is calculated using the formula: 14.89 × Alb level (g/dL) + 41.7 × (current weight/standard weight). The standard weight is determined differently for men and women: for men, it is calculated as height −100 −(height −150)/4, and for women, as height −100 −(height −150)/2.5. If the current weight exceeds the standard weight, the ratio of the current weight to the standard weight is set to 120). The GNRI is suitable in predicting mortality and evaluating the risk of undernutrition in the elderly20).
During the hospitalization period, the participants underwent rehabilitation sessions lasting 20 to 60 min, once or twice daily, 5 to 7 days a week. The rehabilitation program, designed by the physical or occupational therapist under the guidance of a physiatrist, included exercises to improve joint range of motion, muscle strengthening, gait training (using parallel bars, walkers, canes, or unassisted walking), and activities of daily living. The timing of discharge was decided by consensus of the multidisciplinary staff during a conference after the attending physician gave permission for discharge.
The FIMTM score at discharge (total, motor, and cognitive items) and FIMTM effectiveness (total, motor, and cognitive items) were used as dependent variables. Each assessment item (NT-proBNP concentration at admission, age, period from injury to hospitalization, length of hospital stay, estimated glomerular filtration rate at admission, GNRI at admission, FAC before injury, motor FIMTM at admission, cognitive FIMTM at admission, and total FIMTM at admission) was used as an explanatory variable. Multiple regression analysis was conducted using the stepwise method. Prior to the analysis, multicollinearity was assessed to ensure that the correlation coefficients between explanatory variables did not exceed 0.9.
NT-proBNP concentrations were classified into four groups based on the cut-off values for the diagnosis of heart failure in the “Guidelines for the Diagnosis of Acute and Chronic Heart Failure”19) issued by the Japanese Society of Cardiology and the Japan Heart Failure Society: 1) less than 125 pg/mL, 2) 125 pg/mL to less than 400 pg/mL, 3) 400 pg/mL to less than 900 pg/mL, and 4) 900 pg/mL and above. These categories were used as dummy variables. SPSS (version 29) (IBM Corp., Armonk, NY, USA) was used for statistical analyses, and the significance level was set at 5%.
RESULTS
The values of each evaluation item are shown in Table 1. Tables 2, 3, 4 shows the results of a multiple regression analysis examining the relationship between FIMTM scores at discharge and each of the assessment items. In the total FIMTM score at discharge, the total FIMTM score at admission was a significant explanatory variable (p<0.01, β=0.86). The motor FIMTM score at admission (p<0.01, β=0.79) and NT-proBNP concentration (p=0.02, β= −0.21) were significant explanatory variables in the motor FIMTM score at discharge. Furthermore, the cognitive FIMTM score at admission was a significant explanatory variable in the cognitive FIMTM score at discharge (p<0.01, β=0.72). Tables 5, 6 shows the results of a multiple regression analysis exploring the relationship between FIMTM effectiveness and each of the assessment items. NT-proBNP concentration was a significant explanatory variable in both total FIMTM effectiveness and motor FIMTM effectiveness (p<0.01, β=−0.45; p<0.01, β=−0.50). However, no significant results were obtained for cognitive FIMTM effectiveness using the stepwise method.
Table 1. Evaluation item values.
| Evaluation items | Values | |
| Sex (n) | Male | 6 |
| Female | 29 | |
| Age (years) | 87.3 ± 6.4 | |
| Fracture type (n) | Femoral neck fracture | 18 |
| Trochanteric fracture | 17 | |
| Type of surgery (n) | Osteosynthesis | 19 |
| Arthroplasty | 16 | |
| Period from injury to hospitalization (days) | 25.3 ± 10.2 | |
| Length of hospital stay (days) | 46.8 ± 21.9 | |
| NT-proBNP concentration at admission | <125 pg/mL | 8 |
| ≥125 pg/mL, <400 pg/mL | 13 | |
| ≥400 pg/mL, <900 pg/mL | 9 | |
| ≥900 pg/mL | 5 | |
| eGFR at admission (mL/min/1.73 m2) | 67.3 ± 18.9 | |
| GNRI at admission | 94.8 ± 7.9 | |
| HDS-R at admission (score) | 25.9 ± 2.7 | |
| FAC before injury (n) | 4 | 12 |
| 5 | 23 | |
| Total FIMTM at admission (score) | 78.5 ± 18.7 | |
| Motor FIMTM at admission (score) | 48.9 ± 15.6 | |
| Cognitive FIMTM at admission (score) | 28.6 ± 5.1 | |
| Total FIMTM at discharge (score) | 99.7 ± 14.5 | |
| Motor FIMTM at discharge (score) | 68.9 ± 12.2 | |
| Cognitive FIMTM at discharge (score) | 30.8 ± 4.3 | |
| Total FIMTM effectiveness | 0.46 ± 0.16 | |
| Motor FIMTM effectiveness | 0.48 ± 0.16 | |
| Cognitive FIMTM effectiveness | 0.29 ± 0.36 |
eGFR: estimated glomerular filtration rate; GNRI: geriatric nutritional risk index; HDS-R: Hasegawa’s dementia scale; FAC: functional ambulation categories; FIMTM: functional independence measure.
Table 2. Results of multiple regression analysis with Total FIMTM scores at discharge as the dependent variable.
| Unstandardized coefficient |
Standardized coefficient |
p-value | 95% CI | VIF | ||
| Lower limit | Upper limit | |||||
| Total FIMTM at discharge | ||||||
| Constant | 47.21 | <0.001 | 36.09 | 58.33 | ||
| Total FIMTM at admission | 0.67 | 0.86 | <0.001 | 0.53 | 0.81 | 1.00 |
| R2=0.75 | ANOVA p<0.001 | |||||
ANOVA: analysis of variance; FIMTM: functional independence measure; VIF: variance inflation factor.
Table 3. Results of multiple regression analysis with Motor FIMTM scores at discharge as the dependent variable.
| Unstandardized coefficient |
Standardized coefficient |
p-value | 95% CI | VIF | ||
| Lower limit | Upper limit | |||||
| Motor FIMTM at discharge | ||||||
| Constant | 44.05 | <0.001 | 34.11 | 53.98 | ||
| Motor FIMTM at admission | 0.62 | 0.79 | <0.001 | 0.48 | 0.76 | 1.13 |
| NT-proBNP concentration | −2.56 | −0.21 | 0.021 | −4.72 | −0.41 | 1.13 |
| R2=0.79 | ANOVA p<0.001 | |||||
ANOVA: analysis of variance; FIMTM: functional independence measure; VIF: variance inflation factor.
Table 4. Results of multiple regression analysis with Cognitive FIMTM scores at discharge as the dependent variable.
| Unstandardized coefficient |
Standardized coefficient |
p-value | 95% CI | VIF | ||
| Lower limit | Upper limit | |||||
| Cognitive FIMTM at discharge | ||||||
| Constant | 13.46 | <0.001 | 7.37 | 19.54 | ||
| Cognitive FIMTM at admission | 0.61 | 0.72 | <0.001 | 0.40 | 0.81 | 1.00 |
| R2=0.51 | ANOVA p<0.001 | |||||
ANOVA: analysis of variance; FIMTM: functional independence measure; VIF: variance inflation factor.
Table 5. Results of multiple regression analysis with Total FIMTM effectiveness as the dependent variable.
| Unstandardized coefficient |
Standardized coefficient |
p-value | 95% CI | VIF | ||
| Lower limit | Upper limit | |||||
| Total FIMTM effectiveness | ||||||
| Constant | 0.63 | <0.001 | 0.50 | 0.76 | ||
| NT-proBNP concentration | −0.07 | −0.45 | 0.006 | −0.13 | −0.02 | 1.00 |
| R2=0.20 | ANOVA p=0.006 | |||||
ANOVA: analysis of variance; FIMTM: functional independence measure; VIF: variance inflation factor.
Table 6. Results of multiple regression analysis with Motor FIMTM effectiveness as the dependent variable.
| Unstandardized coefficient |
Standardized coefficient |
p-value | 95% CI | VIF | ||
| Lower limit | Upper limit | |||||
| Motor FIMTM effectiveness | ||||||
| Constant | 0.66 | <0.001 | 0.54 | 0.78 | ||
| NT-proBNP concentration | −0.08 | −0.50 | 0.002 | −0.13 | −0.03 | 1.00 |
| R2=0.25 | ANOVA p=0.002 | |||||
ANOVA: analysis of variance; FIMTM: functional independence measure; VIF: variance inflation factor.
DISCUSSION
In this study, we investigated whether admission NT-proBNP concentration could predict discharge FIMTM outcomes among elderly postoperative patients with proximal femur fractures aged 75 years or older. Results showed that NT-proBNP concentrations at admission were predictive of motor FIMTM scores at discharge, as well as total FIMTM effectiveness and motor FIMTM effectiveness. A study describing the effect of heart failure on FIMTM effectiveness after hip fracture reported lower FIMTM effectiveness in patients with a history of heart failure than in those without8). Another study on patients with hip fractures aged 65 years and older found that higher BNP concentrations are associated with lower FIMTM scores and FIMTM effectiveness at discharge9). Specifically, patients with BNP concentrations above 100 pg/mL demonstrate significantly lower FIMTM gains and FIMTM effectiveness10). Consistent with these findings, the present study suggests that NT-proBNP concentration at admission affects FIMTM effectiveness and FIMTM scores at discharge.
The first difference from previous studies is that this study excluded patients with cognitive decline. Research indicates that patients with post-fracture femur who have MMSE scores of 20 or lower tend to show poor improvement in motor FIMTM 21) and reduced ADL independence, particularly among those with dementia, aged 85 or older, and with multiple comorbidities22). This suggests that cognitive impairment may have a considerable impact on improvement in ADL after femur fracture surgery. The second difference lies in the age criteria, where this study focused on patients aged 75 years and older. Prior studies either did not set specific age criteria or included a wide age range starting from 65 years, suggesting that age might have contributed to the decline in ADL capacity. In this study, we excluded patients with cognitive impairment (HDS-R score of 20 or less) and limited the age to 75 years and older, which we believe suppressed the effects of cognitive function and age, thereby providing a more accurate assessment of the impact of NT-proBNP concentration on FIMTM scores at discharge.
This study, which specifically excluded dementia in elderly patients aged 75 years and older, also suggested that heart failure severity was associated with motor scores at discharge and motor FIMTM effectiveness.
We believe that the NT-proBNP concentration was selected as an explanatory factor for the motor FIMTM score at discharge, total FIMTM effectiveness, and motor FIMTM effectiveness in this study for several reasons. First, this choice is rooted in the pathophysiology of heart failure. In heart failure, elevated left ventricular end-diastolic pressure and decreased cardiac output are known to promote the secretion of natriuretic peptides23, 24). Elevated left ventricular end-diastolic pressure, in turn, causes increased left atrial pressure and pulmonary artery wedge pressure25). Obokata et al.26) reported that higher pulmonary capillary wedge pressure in patients with heart failure leads to hyperventilation and an increased respiratory rate during exercise compared with those without heart failure. In this study, NT-proBNP concentrations at admission were classified into four groups based on the cutoff values established by the “Guidelines for the Diagnosis of Acute and Chronic heart failure”19) by the Japanese Society of Cardiology and the Japan Heart Failure Society. However, elevated NT-proBNP concentrations may have caused hyperventilation during exercise, potentially hindering patients’ ability to achieve the adequate level of physical activity.
Second, poor exercise tolerance has been reported to significantly reduce ADL in patients with heart failure27). Peripheral factors, such as skeletal muscle function, are considered more important than central circulating factors, such as cardiac function, in determining exercise intolerance. Specifically, heart failure is associated with a decline in oxidative enzymes, a decrease in type I muscle fibers alongside a relative increase in type II fibers, reduced mitochondrial content, and muscle atrophy28). The association found in this study between NT-proBNP concentrations and motor FIMTM score at discharge, as well as total FIMTM effectiveness and motor FIMTM effectiveness, may be due in part to the effect of heart failure on exercise intolerance.
Third, we considered the effect of heart failure on fracture and soft tissue healing. The general process of fracture healing involves three phases: an inflammatory phase, a repair phase where temporary bone is formed, and a remodeling phase29). Adequate blood circulation is considered important for bone heading30). According to Gurlt30), the average healing time for the femoral neck to tolerate exercise load is approximately 12 weeks. However, factors, such as older age, undernourishment, complications like diabetes, osteoporosis, and a history of steroid use, are believed to prolong bone healing30). In heart failure, increased sympathetic nerve activity and elevated levels of inflammatory cytokines accelerate bone resorption31,32,33), resulting in decreased bone mineral density in the extremities and trunk compared with patients without heart failure34). This reduction in bone mineral density may have affected bone healing. In addition, post-fracture surgery involves the invasion of soft tissues, such as muscle and fascia, whose regeneration requires adequate blood circulation and an acute inflammatory response35). Thus, blood circulation is not only vital for bone healing but also for tissue repair30, 35). We can speculate that high NT-proBNP concentrations may have affected bone healing and soft tissue repair by reducing tissue perfusion due to decreased cardiac output, thus delaying the recovery of physical function. The results of this study suggest that physical therapists should focus on NT-proBNP concentrations because the recovery of motor FIMTM scores in elderly postoperative proximal femur fracture patients without dementia is greatly influenced by heart failure severity.
This study had some limitations. First, it was conducted at a single center, which limits the generalizability of the findings. To build stronger evidence regarding the severity of heart failure in patients with postoperative hip joint, future research should include multicenter studies. Second, the health conditions of elderly patients are characterized by individual variability, multiple chronic diseases, atypical symptoms, and the presence of several comorbidities36). Although this study focused on heart failure severity, examining the comorbidities and complications that affect a patient’s ability to perform ADL is necessary. This approach would allow for more accurate predictions of the FIMTM and functional recovery at discharge. Finally, heart failure severity in this study was assessed solely through NT-proBNP concentration. A more detailed examination could be achieved using cardiac echocardiographic measurements, such as left ventricular ejection fraction and the cardiothoracic ratio from chest X-rays, to classify patients into pathological states, such as systolic and diastolic dysfunction.
Funding
This research received no grant from any funding agency in the public, commercial or not-for-profit sectors.
Conflict of interest
The authors declare that there is no conflict of interest.
Acknowledgments
We would like to thank all of our staff, the patients who participated in the study.
REFERENCES
- 1.2023. White paper on aging society. Chapter 1: Aging population. Section 1: Aging population. 1 Current and future prospects for aging population. https://www8.cao.go.jp/kourei/whitepaper/w-2023/zenbun/05pdf_index.html (Accessed May 8, 2024)
- 2.Azuma K, Kubo K: Bone aging and senile osteoporosis: morphological analyses. Microscopy (Oxf), 2017, 52: 29–34. [Google Scholar]
- 3.Sfeir JG, Drake MT, Khosla S, et al. : Skeletal aging. Mayo Clin Proc, 2022, 97: 1194–1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.The Japanese Orthopaedic Association: The Japanese Society for fracture repair. Guidelines for the treatment of femoral neck/trochanteric fractures 2021, revised 3rd ed. https://minds.jcqhc.or.jp/common/wp-content/plugins/pdfjs-viewer (Accessed May 8, 2024)
- 5.Lloyd-Jones DM, Larson MG, Leip EP, et al. Framingham Heart Study: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 2002, 106: 3068–3072. [DOI] [PubMed] [Google Scholar]
- 6.Ambrosy AP, Fonarow GC, Butler J, et al. : The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol, 2014, 63: 1123–1133. [DOI] [PubMed] [Google Scholar]
- 7.Okura Y, Ramadan MM, Ohno Y, et al. : Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J, 2008, 72: 489–491. [DOI] [PubMed] [Google Scholar]
- 8.Itagaki A, Kakizaki A, Funahashi M, et al. : Impact of heart failure on functional recovery after hip fracture. J Phys Ther Sci, 2019, 31: 277–281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tamamura Y, Matsuura M, Shiba S, et al. : Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture. PLoS One, 2020, 15: e0237387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tamamura Y, Matsuura M, Shiba S, et al. : Effect of heart failure and malnutrition, alone and in combination, on rehabilitation effectiveness in patients with hip fracture. Clin Nutr ESPEN, 2021, 44: 356–366. [DOI] [PubMed] [Google Scholar]
- 11.Kato S: Understanding and using the revised Hasegawa simplified intelligence rating scale (HDS-R). Jpn J Clin Geropsychol, 2023, 4: 47–55. [Google Scholar]
- 12.Toda H, Sakai W, Takahata H: The relationship between nutritional assessment on admission, improvement of ADL, and rate of home return in hip fracture patients. Occup Ther, 2022, 41: 676–685. [Google Scholar]
- 13.Nitsch D, Mylne A, Roderick PJ, et al. : Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant, 2009, 24: 1539–1544. [DOI] [PubMed] [Google Scholar]
- 14.Koh GC, Chen CH, Petrella R, et al. : Rehabilitation impact indices and their independent predictors: a systematic review. BMJ Open, 2013, 3: e003483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Holden MK, Gill KM, Magliozzi MR: Gait assessment for neurologically impaired patients. Standards for outcome assessment. Phys Ther, 1986, 66: 1530–1539. [DOI] [PubMed] [Google Scholar]
- 16.Kishimoto I, Tokudome T, Kangawa K: Natriuretic peptides and their receptor system-mediated cardiovascular protection. Heart, 2009, 41: 1302–1307. [Google Scholar]
- 17.Horii M, Saito Y: Natriuretic peptide and heart failure diagnosis. Heart, 2009, 41: 1308–1313. [Google Scholar]
- 18.Saito Y: Diagnosis and treatment of heart failure based on biomarkers: interpretation of the BNP statement of the Japanese society of heart failure. J Jpn Soc Int Med, 2014, 103: 747–752. [DOI] [PubMed] [Google Scholar]
- 19.The Japanese Circulation Society, The Japanese Heart Failure Society: Guidelines for the treatment of acute and chronic heart failure (revised 2017). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf (Accessed May 8, 2024)
- 20.Bouillanne O, Morineau G, Dupont C, et al. : Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr, 2005, 82: 777–783. [DOI] [PubMed] [Google Scholar]
- 21.Yoshitaka T, Shimaoka Y, Yamanaka I, et al. : Cognitive impairment as the principal factor correlated with the activities of daily living following hip fracture in elderly people. Prog Rehabil Med, 2022, 7: 20220026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tang VL, Sudore R, Cenzer IS, et al. : Rates of recovery to pre-fracture function in older persons with hip fracture: an observational study. J Gen Intern Med, 2017, 32: 153–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ishibashi M: BNP and NT-proBNP in patients with cardiovascular disease usefulness for clinical diagnosis and future prospects. https://www.sysmex.co.jp/products_solutions/library/journal/vol17_no3/bfvlfm000000comg-att/Vol17_3_02.pdf (Accessed May 8, 2024).
- 24.Ishii J: New cardiac function and heart failure biochemical markers: clinical development of N-terminal pro-B-type sodium diuretic peptide (NT-proBNP). Clin Biochem, 2008, 37: 283–291. [Google Scholar]
- 25.Kai H: Advances in epidemiology and basic research. Pathophysiology of chronic heart failure. J Jpn Soc Int Med, 2012, 101: 322–328. [DOI] [PubMed] [Google Scholar]
- 26.Obokata M, Olson TP, Reddy YN, et al. : Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction. Eur Heart J, 2018, 39: 2810–2821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Takada S: Skeletal muscle abnormalities in chronic heart failure. Heart, 2021, 53: 1280–1284. [Google Scholar]
- 28.Okita K, Kinugawa S, Tsutsui H: Exercise intolerance in chronic heart failure—skeletal muscle dysfunction and potential therapies. Circ J, 2013, 77: 293–300. [DOI] [PubMed] [Google Scholar]
- 29.Nakajima A, Yamazaki M, Takahashi K: Recent progress in fracture healing research through molecular and cellular biology. https://opac.ll.chiba-u.jp/da/curator/900066680/86-3-83.pdf (Accessed May 8, 2024)
- 30.Kubota M, Kokubo Y: Effective rehabilitation after fracture. Jpn J Electrophysical Agents, 2019, 26: 21–26. [Google Scholar]
- 31.Kato M, Kurita Y, Tsukamoto T, et al. : Autonomic nerve and circulation control via exercise therapy. Auton Nerv Syst, 2022, 59: 307–310. [Google Scholar]
- 32.Takeda S: Regulatory mechanism of bone metabolism. https://jsn.or.jp/journal/document/56_8/1188-1195.pdf (Accessed May 8, 2024)
- 33.Loncar G, Cvetinovic N, Lainscak M, et al. : Bone in heart failure. J Cachexia Sarcopenia Muscle, 2020, 11: 381–393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Xing W, Lv X, Gao W, et al. : Bone mineral density in patients with chronic heart failure: a meta-analysis. Clin Interv Aging, 2018, 13: 343–353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yuasa M, Gibson B, Schoenecker J: Fibrinolytic system in tissue healing: bone and muscle. Jpn J Thromb Hemost, 2020, 31: 373–380. [Google Scholar]
- 36.Hashimoto M: Basic knowledge of medical care for the elderly. J Jpn Soc Int Med, 2018, 107: 2415–2419. [Google Scholar]
